Healthcare Equipment and Supplies
Company Overview of Singulex, Inc.
Singulex, Inc. develops and provides single molecule counting (SMC) technology for clinical diagnostics and scientific discovery. The company offers Sgx Clarity System, an immunodiagnostic platform that is designed to detect low abundance biomarkers at levels down to femtograms/mL. Its system provides proactive cardiovascular health management for clinicians; heart disease and wellness monitoring services for patients; and personalized wellness programs and clinical health education to patients and physicians. It also provides ultra-sensitive immunoassay solutions and laboratory testing services that help patient care from reactive disease treatment to proactive health management and fueling...
1701 Harbor Bay Parkway
Alameda, CA 94502
Founded in 1997
Key Executives for Singulex, Inc.
Chief Executive Officer, President and Director
Senior Vice President of Operations
Vice President of Human Resources
Compensation as of Fiscal Year 2016.
Singulex, Inc. Key Developments
Singulex Enters into World-Wide Service Agreement with Tecan
Jul 5 16
Singulex, Inc. announced the conclusion of a world-wide service agreement with Tecan Group to deliver comprehensive maintenance and support for its Sgx Clarity(TM) System. The Sgx Clarity System, currently in development and not yet approved for sale, is a fully automated, Next Generation Immunodiagnostics platform designed to bring the benefits of Singulex's SMC technology to hospital and reference labs worldwide. It is designed to overcome the existing sensitivity barriers in immunochemistry diagnostics. Through the agreement, Tecan will deliver comprehensively scheduled maintenance and technical support. Once the Sgx Clarity System is approved for sale, hospital and reference labs will have access to next generation immunodiagnostics with sensitivity targets that are more than 100-times greater than currently available devices and the confidence of expert maintenance and support across the globe.
Grifols Signs Licensing Agreement with Singulex
May 20 16
Grifols, S.A. has entered into a worldwide license agreement with Singulex, Inc. for the use and commercialization of Singulex's technology for screening plasma and blood donation that allows garnatizar further the safety of transfusions and plasma products.
Singulex, Inc. Presents at JPMorgan 34th Annual Healthcare Conference, Jan-14-2016 10:00 AM
Jan 6 16
Singulex, Inc. Presents at JPMorgan 34th Annual Healthcare Conference, Jan-14-2016 10:00 AM. Venue: Westin St. Francis Hotel, 335 Powell Street, San Francisco, California, United States. Speakers: Guido Baechler, Chief Executive Officer, President and Director.
Similar Private Companies By Industry
Recent Private Companies Transactions
May 17, 2016
The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create
or control the content. For inquiries, please contact Capital IQ directly by clicking
Most Searched Private Companies
Sponsored Financial Commentaries